We are live on ! Find out more
IVVD icon

Invivyd

79 hedge funds and large institutions have $42.6M invested in Invivyd in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

228% more call options, than puts

Call options by funds: $118K | Put options by funds: $36K

25% more capital invested

Capital invested by funds: $34M → $42.6M (+$8.6M)

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 7779 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5.5% less ownership

Funds ownership: 64.19%58.69% (-5.5%)

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

Holders
79
Holders Change
+2
Holders Change %
+2.6%
% of All Funds
1.06%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
16
Increased
21
Reduced
25
Closed
14
Calls
$118K
Puts
$36K
Net Calls
+$82K
Net Calls Change
+$81K
Name Holding Trade Value Shares
Change
Change in
Stake
MIG
1
Mithril II GP
Texas
$6.8M
MC
2
Maverick Capital
Texas
$6.63M -$724K -807,215 -7%
DTC
3
Deep Track Capital
Connecticut
$5.88M -$868K -967,349 -9%
MCM
4
M28 Capital Management
Connecticut
$5.6M
BlackRock
5
BlackRock
New York
$3.24M +$543K +605,758 +13%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.66M +$51.2K +57,127 +1%
6CM
7
683 Capital Management
New York
$1.82M
RG
8
Redmile Group
California
$1.38M -$652K -726,934 -24%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$1.25M -$3.33M -3,714,554 -64%
BCLSI
10
Bain Capital Life Sciences Investors
Massachusetts
$1.09M
Geode Capital Management
11
Geode Capital Management
Massachusetts
$984K +$25.1K +27,980 +2%
State Street
12
State Street
Massachusetts
$604K -$133K -148,636 -13%
O
13
OrbiMed
New York
$565K -$194K -215,800 -19%
Morgan Stanley
14
Morgan Stanley
New York
$449K +$485K +540,176 +269%
Deutsche Bank
15
Deutsche Bank
Germany
$400K -$197K -219,128 -25%
Northern Trust
16
Northern Trust
Illinois
$357K +$27.3K +30,442 +5%
DFO
17
Duquesne Family Office
New York
$346K
UBS Group
18
UBS Group
Switzerland
$267K +$47.8K +53,331 +14%
AQR Capital Management
19
AQR Capital Management
Connecticut
$249K +$351K +391,617 +2,051%
TCM
20
Tang Capital Management
California
$242K +$62.6K +69,828 +21%
Citadel Advisors
21
Citadel Advisors
Florida
$158K +$175K +195,142 +298%
Goldman Sachs
22
Goldman Sachs
New York
$155K +$5.22K +5,817 +2%
Two Sigma Investments
23
Two Sigma Investments
New York
$146K -$113K -126,493 -34%
GCP
24
GSA Capital Partners
United Kingdom
$117K -$242K -269,778 -58%
Charles Schwab
25
Charles Schwab
California
$113K

IVVD Hedge Fund Activity: Q1 2025 in Review

79 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Invivyd (IVVD) for Q1 2025, worth a combined $42.6M — up 25% from $34M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new IVVD positions and 14 closed out — a net gain of 2 holders — while 21 added to existing stakes and 25 trimmed.

The largest buyer was BlackRock, adding an estimated $543K. The largest seller was Fidelity Investments, cutting an estimated $3.33M.

  • 79 institutional investors held Invivyd (IVVD) as of Q1 2025, up from 77 in Q4 2024.
  • Funds reported $42.6M of Invivyd stock for Q1 2025, up 25% quarter-over-quarter.
  • 16 funds opened new Invivyd positions in Q1 2025 and 14 closed out, a net change of +2 holders.
  • The largest Invivyd buyer in Q1 2025 was BlackRock, an estimated $543K added.
  • The largest Invivyd seller in Q1 2025 was Fidelity Investments, an estimated $3.33M sold.

Based on aggregated 13F filings for Q1 2025.